In adults with postherpetic neuralgia, neurontin therapy may be initiated as a single 300-mg dose on day 1, 600 mg/day on day 2 in divided doses and 900 mg/day on day 3 in divided doses. Patients > 12 ...
Zydus Lifesciences Limited reported that it secured final approval from the United States Food and Drug Administration (USFDA) for manufacturing and marketing Gabapentin Tablets (Once-Daily), ...
Strides Pharma Science has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for gabapentin tablets USP, 600 mg and 800 mg, ...
MENLO PARK, Calif., Jan. 28, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that US FDA has approved GRALISE™ (gabapentin) Tablets for once-daily treatment of post-herpetic ...
Gabapentin tablets are indicated for management of postherpetic neuralgia in adults; and as an adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalisation, ...
HUNTINGTON BEACH, California ― Gabapentin (multiple brands) is increasingly being used by patients in methadone maintenance programs to get high, and this can put them at risk for accidents, injuries, ...
The US Food and Drug Administration's (FDA's) expert panel on reproductive health drugs has voted against approval of 2 nonhormonal options for the treatment of moderate to severe vasomotor symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback